-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The reporter learned from the First Affiliated Hospital of Xi’an Jiaotong University (hereinafter referred to as the First Affiliated Hospital of Xi’an Jiaotong University) on the 8th that the country’s first extracorporeal membrane oxygenation equipment (hereinafter referred to as: ECMO) was first used in clinical practice by the First Affiliated Hospital of Xi’an Jiaotong University in China.
, Successfully treated two critical cardiovascular patients
.
, Successfully treated two critical cardiovascular patients
.
According to reports, a patient in the First Affiliated Hospital of Xi’an Jiaotong University was diagnosed with type A aortic dissection and was admitted to the hospital.
After the operation, he developed severe hypoxemia due to inflammatory reaction.
After mechanical ventilation, the oxygenation did not improve.
After communicating with the patient’s family, the hospital The patient was treated with VV-ECMO (venous to vein), and the patient's blood oxygen gradually improved
.
Another patient in this hospital had aortic valve insufficiency, ascending aortic aneurysm dilation, acute left heart failure, emergency surgery after admission, postoperative cardiac function was low, and VA-ECMO (venous to artery ) Auxiliary cardiac therapy, the patient's condition is stable after operation
.
After medical evaluation, the above two patients were successfully withdrawn from ECMO
.
After the operation, he developed severe hypoxemia due to inflammatory reaction.
After mechanical ventilation, the oxygenation did not improve.
After communicating with the patient’s family, the hospital The patient was treated with VV-ECMO (venous to vein), and the patient's blood oxygen gradually improved
.
Another patient in this hospital had aortic valve insufficiency, ascending aortic aneurysm dilation, acute left heart failure, emergency surgery after admission, postoperative cardiac function was low, and VA-ECMO (venous to artery ) Auxiliary cardiac therapy, the patient's condition is stable after operation
.
After medical evaluation, the above two patients were successfully withdrawn from ECMO
.
Since the emergence of the new coronary pneumonia epidemic in early 2020, ECMO has gradually become known to the public as a powerful "weapon" for the treatment of patients with severe cardiopulmonary failure
.
However, its core key technology has been monopolized by foreign countries for a long time, and the equipment and consumables are expensive
.
.
However, its core key technology has been monopolized by foreign countries for a long time, and the equipment and consumables are expensive
.
It is reported that the first domestic ECMO was jointly developed by the First Affiliated Hospital of Xi'an Jiaotong University , the National Engineering Research Center for Biomedical Materials of Sichuan University, and the School of Mechanical Engineering of Xi'an Jiaotong University
.
Before the outbreak of the new crown epidemic in 2020, the R&D team has basically completed the trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulation coatings
.
.
Before the outbreak of the new crown epidemic in 2020, the R&D team has basically completed the trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulation coatings
.
It is understood that the R&D team fully analyzed and compared the advantages and disadvantages of similar foreign products and the problems in clinical use, and designed a localized ECMO for domestic clinical needs
.
In the research and development, multi-objective optimization and numerical simulation methods are used to obtain the optimal design scheme for the flow channel of the centrifugal pump.
The chip-based control mode is used to ensure the accuracy of ECMO control and the safety of long-time work.
The product has a more excellent long-term circulating anticoagulant effect
.
.
In the research and development, multi-objective optimization and numerical simulation methods are used to obtain the optimal design scheme for the flow channel of the centrifugal pump.
The chip-based control mode is used to ensure the accuracy of ECMO control and the safety of long-time work.
The product has a more excellent long-term circulating anticoagulant effect
.
The First Affiliated Hospital of Xi’an Jiaotong University stated that the domestic ECMO was successfully applied in clinical practice, breaking the monopoly of foreign products in this field, achieving a breakthrough in the independent research and development of major domestic medical devices , and breaking the "card" for the treatment of critically ill patients with cardiovascular disease.
The "neck" problem is another major scientific research achievement of the hospital in establishing the National Medical Center
.
(over)
The "neck" problem is another major scientific research achievement of the hospital in establishing the National Medical Center
.
(over)
The reporter learned from the First Affiliated Hospital of Xi’an Jiaotong University (hereinafter referred to as the First Affiliated Hospital of Xi’an Jiaotong University) on the 8th that the country’s first extracorporeal membrane oxygenation equipment (hereinafter referred to as: ECMO) was first used in clinical practice by the First Affiliated Hospital of Xi’an Jiaotong University in China.
, Successfully treated two critical cardiovascular patients
.
, Successfully treated two critical cardiovascular patients
.
According to reports, a patient in the First Affiliated Hospital of Xi’an Jiaotong University was diagnosed with type A aortic dissection and was admitted to the hospital.
After the operation, he developed severe hypoxemia due to inflammatory reaction.
After mechanical ventilation, the oxygenation did not improve.
After communicating with the patient’s family, the hospital The patient was treated with VV-ECMO (venous to vein), and the patient's blood oxygen gradually improved
.
Another patient in this hospital had aortic valve insufficiency, ascending aortic aneurysm dilation, acute left heart failure, emergency surgery after admission, postoperative cardiac function was low, and VA-ECMO (venous to artery ) Auxiliary cardiac therapy, the patient's condition is stable after operation
.
After medical evaluation, the above two patients were successfully withdrawn from ECMO
.
After the operation, he developed severe hypoxemia due to inflammatory reaction.
After mechanical ventilation, the oxygenation did not improve.
After communicating with the patient’s family, the hospital The patient was treated with VV-ECMO (venous to vein), and the patient's blood oxygen gradually improved
.
Another patient in this hospital had aortic valve insufficiency, ascending aortic aneurysm dilation, acute left heart failure, emergency surgery after admission, postoperative cardiac function was low, and VA-ECMO (venous to artery ) Auxiliary cardiac therapy, the patient's condition is stable after operation
.
After medical evaluation, the above two patients were successfully withdrawn from ECMO
.
Since the emergence of the new coronary pneumonia epidemic in early 2020, ECMO has gradually become known to the public as a powerful "weapon" for the treatment of patients with severe cardiopulmonary failure
.
However, its core key technology has been monopolized by foreign countries for a long time, and the equipment and consumables are expensive
.
.
However, its core key technology has been monopolized by foreign countries for a long time, and the equipment and consumables are expensive
.
It is reported that the first domestic ECMO was jointly developed by the First Affiliated Hospital of Xi'an Jiaotong University , the National Engineering Research Center for Biomedical Materials of Sichuan University, and the School of Mechanical Engineering of Xi'an Jiaotong University
.
Before the outbreak of the new crown epidemic in 2020, the R&D team has basically completed the trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulation coatings
.
.
Before the outbreak of the new crown epidemic in 2020, the R&D team has basically completed the trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulation coatings
.
It is understood that the R&D team fully analyzed and compared the advantages and disadvantages of similar foreign products and the problems in clinical use, and designed a localized ECMO for domestic clinical needs
.
In the research and development, multi-objective optimization and numerical simulation methods are used to obtain the optimal design scheme for the flow channel of the centrifugal pump.
The chip-based control mode is used to ensure the accuracy of ECMO control and the safety of long-time work.
The product has a more excellent long-term circulating anticoagulant effect
.
.
In the research and development, multi-objective optimization and numerical simulation methods are used to obtain the optimal design scheme for the flow channel of the centrifugal pump.
The chip-based control mode is used to ensure the accuracy of ECMO control and the safety of long-time work.
The product has a more excellent long-term circulating anticoagulant effect
.
The First Affiliated Hospital of Xi’an Jiaotong University stated that the domestic ECMO was successfully applied in clinical practice, breaking the monopoly of foreign products in this field, achieving a breakthrough in the independent research and development of major domestic medical devices , and breaking the "card" for the treatment of critically ill patients with cardiovascular disease.
The "neck" problem is another major scientific research achievement of the hospital in establishing the National Medical Center
.
(over)
The "neck" problem is another major scientific research achievement of the hospital in establishing the National Medical Center
.
(over)
The reporter learned from the First Affiliated Hospital of Xi’an Jiaotong University (hereinafter referred to as the First Affiliated Hospital of Xi’an Jiaotong University) on the 8th that the country’s first extracorporeal membrane oxygenation equipment (hereinafter referred to as: ECMO) was first used in clinical practice by the First Affiliated Hospital of Xi’an Jiaotong University in China.
, Successfully treated two critical cardiovascular patients
.
, Successfully treated two critical cardiovascular patients
.
According to reports, a patient in the First Affiliated Hospital of Xi’an Jiaotong University was diagnosed with type A aortic dissection and was admitted to the hospital.
After the operation, he developed severe hypoxemia due to inflammatory reaction.
After mechanical ventilation, the oxygenation did not improve.
After communicating with the patient’s family, the hospital The patient was treated with VV-ECMO (venous to vein), and the patient's blood oxygen gradually improved
.
Another patient in this hospital had aortic valve insufficiency, ascending aortic aneurysm dilation, acute left heart failure, emergency surgery after admission, postoperative cardiac function was low, and VA-ECMO (venous to artery ) Auxiliary cardiac therapy, the patient's condition is stable after operation
.
After medical evaluation, the above two patients were successfully withdrawn from ECMO
.
Heart, heart, heartAfter the operation, he developed severe hypoxemia due to inflammatory reaction.
After mechanical ventilation, the oxygenation did not improve.
After communicating with the patient’s family, the hospital The patient was treated with VV-ECMO (venous to vein), and the patient's blood oxygen gradually improved
.
Another patient in this hospital had aortic valve insufficiency, ascending aortic aneurysm dilation, acute left heart failure, emergency surgery after admission, postoperative cardiac function was low, and VA-ECMO (venous to artery ) Auxiliary cardiac therapy, the patient's condition is stable after operation
.
After medical evaluation, the above two patients were successfully withdrawn from ECMO
.
Since the emergence of the new coronary pneumonia epidemic in early 2020, ECMO has gradually become known to the public as a powerful "weapon" for the treatment of patients with severe cardiopulmonary failure
.
However, its core key technology has been monopolized by foreign countries for a long time, and the equipment and consumables are expensive
.
.
However, its core key technology has been monopolized by foreign countries for a long time, and the equipment and consumables are expensive
.
It is reported that the first domestic ECMO was jointly developed by the First Affiliated Hospital of Xi'an Jiaotong University , the National Engineering Research Center for Biomedical Materials of Sichuan University, and the School of Mechanical Engineering of Xi'an Jiaotong University
.
Before the outbreak of the new crown epidemic in 2020, the R&D team has basically completed the trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulation coatings
.
Hospital hospital hospital.
Before the outbreak of the new crown epidemic in 2020, the R&D team has basically completed the trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulation coatings
.
It is understood that the R&D team fully analyzed and compared the advantages and disadvantages of similar foreign products and the problems in clinical use, and designed a localized ECMO for domestic clinical needs
.
In the research and development, multi-objective optimization and numerical simulation methods are used to obtain the optimal design scheme for the flow channel of the centrifugal pump.
The chip-based control mode is used to ensure the accuracy of ECMO control and the safety of long-time work.
The product has a more excellent long-term circulating anticoagulant effect
.
.
In the research and development, multi-objective optimization and numerical simulation methods are used to obtain the optimal design scheme for the flow channel of the centrifugal pump.
The chip-based control mode is used to ensure the accuracy of ECMO control and the safety of long-time work.
The product has a more excellent long-term circulating anticoagulant effect
.
The First Affiliated Hospital of Xi’an Jiaotong University stated that the domestic ECMO was successfully applied in clinical practice, breaking the monopoly of foreign products in this field, achieving a breakthrough in the independent research and development of major domestic medical devices , and breaking the "card" for the treatment of critically ill patients with cardiovascular disease.
The "neck" problem is another major scientific research achievement of the hospital in establishing the National Medical Center
.
(over)
Medical equipment medical equipment medical equipment The "neck" problem is another major scientific research achievement of the hospital in establishing the National Medical Center
.
(over)
